Genomic analysis of 293 basal cell carcinoma (BCC) tumors identified recurrent MYCN missense mutations in 30% of these cases, mapping to MBI (P44L, P44S, or P44F) [149]. Here, MYCN is linked to skin basal cell carcinoma.